Related Experiment Videos
pRB2/p130 target genes in non-small lung cancer cells identified by microarray analysis
Giuseppe Russo1, Pier Paolo Claudio, Yan Fu
1Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA.
Oncogene
|October 10, 2003
Summary
Researchers identified genes regulated by RB2/p130, a protein crucial for cell cycle control. This study enhances understanding of lung carcinoma development and may reveal new therapeutic biomarkers.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- The retinoblastoma gene family (RB/p105, p107, RB2/p130) regulates cell cycle progression.
- Reduced RB2/p130 expression is linked to lung carcinoma development and progression.
- RB2/p130 mutations are found in lung cancer cell lines and primary tumors.
Purpose of the Study:
- To identify genes regulated by RB2/p130 in lung cancer.
- To understand the role of RB2/p130 in lung carcinoma pathogenesis.
Main Methods:
- Adenovirus-mediated expression of RB2/p130 in a non-small lung cancer cell line.
- Oligonucleotide microarrays to identify gene expression changes.
- Semiquantitative RT-PCR and Western blot analysis for validation.
Main Results:
- Identified numerous RB2/p130-downregulated genes.
- Confirmed regulation of specific genes by RB2/p130.
- Observed significant expression modification in 40 genes post-transduction.
Conclusions:
- Adenoviral overexpression combined with microarray and RT-PCR is effective for identifying target genes.
- Findings provide insights into RB2/p130-mediated gene expression profiles.
- Results may aid in discovering novel therapeutic biomarkers for lung carcinoma.